Ultram and Neurogenic bladder - a phase IV clinical study of FDA data

Summary:

Neurogenic bladder is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 40-49 old, also take Lyrica, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Neurogenic bladder when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Neurogenic bladder?

Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion) is found to be associated with 470 drugs and 570 conditions by eHealthMe. Check the latest studies of Neurogenic bladder.

On Jul, 14, 2026

26,802 people reported to have side effects when taking Ultram.
Among them, 32 people (0.12%) have Neurogenic bladder.

Among these 32 people:

What is the gender of people who have Neurogenic bladder when taking Ultram? *

female: 95.24 %
male: 4.76 %

What is the age of people who have Neurogenic bladder when taking Ultram? *

What are other drugs people take besides Ultram? *

What are other side effects people have besides Neurogenic bladder? *

Joint Pain: 27 people, 84.38%
Stress And Anxiety: 27 people, 84.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 26 people, 81.25%
Depression: 26 people, 81.25%
Weakness: 24 people, 75.00%
Muscle Spasms (muscle contraction): 23 people, 71.88%
High Blood Pressure: 22 people, 68.75%
Urinary Retention (the inability to completely or partially empty the bladder): 21 people, 65.62%
Muscle Aches (muscle pain): 21 people, 65.62%
Dyskinesia (abnormality or impairment of voluntary movement): 21 people, 65.62%

What are the existing conditions these people have? *

Stress And Anxiety: 19 people, 59.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 9.38%
Neuritis (inflammation of nerve): 2 people, 6.25%
Constipation: 2 people, 6.25%
Breast Cancer Metastatic: 1 person, 3.12%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and have Neurogenic bladder?

- Check whether Neurogenic bladder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultram:

Ultram (28,425 reports)

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurogenic bladder:

Neurogenic bladder (470 drugs)

Browse all the conditions that are associated with Neurogenic bladder:

Neurogenic bladder (570 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.